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Background and objective: Failure to recruit sufficient numbers of participants is a 
major barrier to the completion of randomized controlled trials in traditional Chinese 
medicine (TCM) clinical trials. The purpose of this paper is to analyze the commonly 
used strategies for the recruitment of patients in TCM clinical trials, to identify the most 
common reasons for attrition and refusal, and to identify barriers and potential solutions 
to the difficulties.
Methods and results: There are four stages in the actual recruitment process, which included 
introducing the project to the potential patients, explaining how to implement the project, 
assessing and intensifying the understanding and facilitating patient decision-making. When 
insufﬁ  cient recruitment occurred, the following steps should be considered: reevaluating the 
required sample size; adding new sites to the trial; eliminating hospitals that had poor recruiting 
records; extending the patient recruitment period, modifying the patient inclusion/exclusion 
criteria; and shifting placebo-controlled to active-controlled arrangements. Success in reaching 
target recruitment depended largely on being able to directly contact patients through posters, 
newspaper advertisements, television interviews, patient support groups, and physician referrals 
in hospitals.
Conclusions: Suspicions against the placebo and unwillingness to stop taking other herbal 
supplements made recruitment more difﬁ  cult, time-consuming, and costly. In a Chinese 
community, open advertising in the local newspaper may be particularly attractive.
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Introduction
The randomized controlled trial (RCT) is widely accepted as the most powerful research 
method in the evaluation of the efﬁ  cacy of a study medication (Ross et al 1999). These 
principles are also applied to traditional Chinese medicine (TCM) studies (Leung et al 
2008). Efﬁ  cient and effective recruitment of patients and retention of participants are 
essential steps in the clinical trials. However, it has been shown that the most eligible 
patients do not participate in clinical trials. A study reported that in eligible patients who 
were aware of an appropriate clinical trial, 71% choose not to participate (Anderson 
2001). In some RCTs, the dropout rate was as high as 80% (Kemmler et al 2005). 
The results of recruitment are generally inﬂ  uenced by a number of factors, including 
the nature of the study itself, the recruitment strategy used, and the target population 
(Taylor-Davis et al 1998). In this paper, we examine some particular barriers to patient 
participation and explore possible solutions.
TCM and herbal medications have remained very popular in Chinese societies 
around the world because it has developed within a culture that has endured for more 
than 3000 years over a vast geographical area with an enormous population. Centuries Patient Preference and Adherence 2008:2 208
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of empirical studies and accumulated experience has retained 
good and useful medical practices while what was not 
effective was discarded. There still remains an high incidence 
of side effect and toxicity as well as TCM not providing 
expected beneﬁ  ts. Nowadays, when modern medicine fails 
to provide the expected beneﬁ  ts, TCM could be considered 
as a last resort; so an unrealistic perspective often exists 
in participants. It may therefore be easier to conduct TCM 
clinical trials in the Chinese community; however, barriers 
or difﬁ  culties still exist.
Process of recruitment
It is important to deﬁ  ne clearly the target population to be 
studied, which depends on the study protocol. The difﬁ  culty 
of recruitment depends on the exclusion/inclusion criteria, 
age, study medication, disease risk factor, biomarkers tested, 
stage of disease, etc. In our TCM clinical trials, the target 
populations are usually those with chronic diseases or with 
their conditions under control. Modern medicine has failed to 
obtain perfect solutions for chronic diseases or conditions that 
include allergic conditions, autoimmune diseases, cancers, 
chronic pain, chronic derangements, degenerative diseases, 
nerve damages, viral infections, etc. Our experiences tell us 
these patients would be willing to participate in TCM clinical 
trials because modern medicine is unable to help them.
There are four stages in the actual recruitment process, 
which are clearly dynamic and interactive (Harris and Dyson 
2001). These stages include:
1.  Introducing the project to the potential patients
2.  Explaining how to implement the project
3.  Assessing and intensifying the understanding
4. Facilitating  patients’  decision-making.
The process of screening started at the time of initial 
contact with the study team, either in person or over the 
telephone. The initial approach is considered vital. It is 
essential that someone is assigned to telephone duty to deal 
with initial contact to avoid loss of potential volunteers. The 
primary purpose is to put the patient at ease and to establish 
rapport between patient and research team quickly. Table 1 
lists our means that we usually use in our clinical trial center 
during the initial approach stage.
When subjects called in response to the initial approach, 
the research nurse noted down their names, a contact tele-
phone number to start screening on related eligibility criteria, 
and whether they were using an herbal preparation. If a 
candidate who was using any herbal preparation was willing 
to participate the trial, our research nurse would advise the 
candidate to stop the herbal preparation for a suitable period 
(washout period) according to the requirement of the study 
protocol before they are enrolled. If the telephone screening 
criteria were met, the research nurse would arrange a proper 
interview for informed consent. Participants then progressed 
to laboratory testing for necessary function assessments. If 
the inclusion/exclusion criteria were satisﬁ  ed and informed 
consent forms were obtained, the participants progressed to 
randomization to either TCM treatment group or placebo 
group.
Barriers and strategies 
of recruitment
Explicit inclusion/exclusion criteria are essential elements of 
any clinical studies. According to the trial protocol, potential 
subjects for TCM trial had to satisfy the inclusion/exclusion 
criteria. Their participation was quite different from visiting 
their general practitioner. If the inclusion/exclusion criteria 
of TCM clinical trials were too rigorous, the difﬁ  culty of 
recruitment is increased. For example, we had conducted 
a RCT by using a Chinese herbal formula named DBT to 
Table 1 Initial approach to patients
Initial approach Our experience
Advertisement (newspapers) TCM for postmenopausal symptoms
Public seminars Herbal formula for lung and colon cancer
Published articles (usually in newspapers) TCM for postmenopausal symptoms
Television interview TCM and postmenopausal symptoms
Physician referral TCM for diabetic foot ulcer
Outpatient/inhouse physician referral TCM for inﬂ  uenza prevention
Friend or acquaintance referral TCM for inﬂ  uenza prevention
Nonproﬁ  t and nongovernment organizations (NGO) Herbal formula for lung and colon cancer
Community (letters and posters) Acupuncture for smoking cessation, osteoporosis study
University collaboration TCM formulas for post-stroke and insomnia
Abbreviation: TCM, traditional Chinese medicine.Patient Preference and Adherence 2008:2 209
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control post-menopausal symptoms. The protocol required 
that subjects should have at least 14 hot ﬂ  ushes per week and 
had not undergone any treatment including hormone therapy 
and herbal treatment, before they entered the study and during 
the study period. We initially approached 452 candidates, 
after screening, only 60 subjects were eligible, ﬁ  nally only 
52 subjects completed the clinical trial (Table 2). Sometimes, 
we needed to identify particular Chinese herbs which were 
consumed by participants themselves to judge if there were 
any interaction with the study TCM medication. In this case, 
we advised the subjects to stop using these herbs before they 
were enrolled and during study period. However, many can-
didates were unwilling to do so. To deal with this problem, 
we advised the candidate keep using the herbal preparation 
during study period, if our TCM practitioner found that the 
herbal preparation would not interfere with study herbal 
medication. To minimize the outcome bias, we treated this 
case very carefully. If we could not ensure whether the herbal 
preparation taken by the candidate had any interaction with 
the study herbal medication, and the candidate was unwilling 
to stop taking his/her herbal preparation, we had to exclude 
the candidate.
The recruitment procedures are not straightforward. To 
enhance recruitment through television interviews, newspaper 
releases, and advertisements to make use of media would be 
very useful. However, to arrange screening interviews with 
patients and retaining them in the trial without drop out was 
even more difﬁ  cult.
Liaising with local organizations and collaborating with 
local practitioners would be helpful for recruitment, especially 
when nonproﬁ  t organizations were involved. Referral from 
physicians was another channel of recruitment, but it had not 
been a main channel in Hong Kong. In our experience, recruit-
ing patients through the health services (hospital consultants, 
general practitioners, and clinics) is likely to be less successful 
because professional heath specialists had other priorities.
In general, the means of initial contact with potential 
volunteers that we targeted in our TCM clinical trials 
included advertisements and relevant articles in newspapers, 
public seminars, television interviews, announcements in 
community centers, etc (Table 1). Appeals in newsletters may 
also be helpful but not as the primary channel for recruitment. 
According to our experience, advertising in local newspapers 
and announcements in community centers are effective. But 
an optimal approach should depend on the nature of the study. 
For example, announcements in community centers were efﬁ  -
cient for nonspeciﬁ  c diseases/conditions such as a smoking 
cessation trial and menopausal symptoms. Considering the 
main channel of initial approach should be depend on the 
nature of study disease/condition. For the diseases/symptoms 
eg, postmenopausal symptoms, that the public have been 
aware of and with a higher prevalence, the initial approach 
through advertisement would be more efﬁ  cient. For those 
that were speciﬁ  c or rare in prevalence, eg, diabetic foot 
ulcer, a referral by physicians was the best way. For most 
diseases/conditions, multiple approaches were needed.
Poor clinical trial recruitment and retention impede the 
successful evaluation of new and existing interventions, 
and delay processes of clinical implementation (Spilker 
and Cramer 1992). Patients may not want to take a chance 
with randomization in an environment where the patients’ 
enthusiasm is often in favor of TCM and against receiving 
a control treatment or no treatment. Another cause of low 
recruitment especially for TCM trial is the dosage form and 
taste of the study herbal preparations. Dosage forms of  TCM 
usually include capsules, tablets, pills, sachets, and oral liq-
uids. If the study drug was prepared in oral liquid and the taste 
was not good, and a large amount of doses was required to 
consume, the difﬁ  culty of recruitment is increased. We used 
to have a TCM clinical trial which required the participants 
to take up to 12 TCM capsules daily for 6 months. We found 
the difﬁ  culty in recruitment increased signiﬁ  cantly and 
compliance decreased.
Besides, many candidates were worried about whether the 
study herbal preparation could change their body nature, for 
example, let them become hot or cold. If they believed some 
ingredients in the formula could change their body nature, 
they might refuse to participate in the trial. To reduce their 
worries, we had a TCM practitioner to provide consultation 
to the participants during study period.
Some candidates wondered if certain foods should be 
avoided during taking the study herbal preparation. It would 
be inconvenient for participants if some herbal soups are to 
be avoided for several months. This was certainly a barrier 
for recruitment. Another barrier was the study duration. The 
efﬁ  cacy of TCM was usually believed to be slow, which 
Table 2 Patient recruitment for a traditional Chinese medicine 
formula trial
Process of recruitment Case
Initial approach 452
Assessed for eligibility 71
Screen failures 11
Enrolled/randomized 60
Drop out 9
Completed 52Patient Preference and Adherence 2008:2 210
King-Fai et al
made the duration of the clinical trial longer. This keeps the 
subjects stay with the clinical trial a quite long time, and 
certainly increased the difﬁ  culty of recruitment and retention. 
Furthermore, long duration of trial might lead to delay of 
proper treatment, or worsening of the disease.
Randomized controlled trials of new treatment often 
include a control group receiving no treatment or placebo. 
However, as patients often assume that a new TCM treatment 
is likely to be effective, recruitment to trials with a placebo 
arm is more difﬁ  cult than recruitment to those of active 
treatment ( Welton et al 1999). No one liked to be assigned to 
take placebo or go without treatment for a long-term period; 
they believed that they are likely to be exposed to a higher risk 
of disease deterioration compared with standard treatment. 
Therefore, greater reluctance from physicians and patients 
to participate in such designed study are expected (Roberts 
et al 2002; Hummer et al 2003). Some subjects were willing 
to participate in the trial but did not want to discontinue 
their concomitant complementary or alternative medicines, 
which they ﬁ  rmly believe would support their good health. 
So willingness to enter a randomized controlled trial of TCM 
would be lower when the trial included a placebo arm.
The barriers to recruitment also came from fear, distrust, 
or misunderstanding of the clinical trial process, unwilling to 
take herbal medication, unacceptable to some ingredient(s) 
of study TCM formula or they would not be treated like a 
“guinea pig”. We conducted a randomized placebo controlled 
double blind clinical trial to investigate the efﬁ  cacy of 
Coriolus Versicolor (Yunzhi) in breast cancer treatment. In 
this study, nearly 98% subjects were already taking other 
herbal drugs. They were reluctant to be randomized for fear 
of inclusion into the placebo group. Eventually, we had to 
compromise and change the inclusion criteria, allowed those 
taking herbal products to participate as long as they stick to 
use their herbal product without change during study period. 
From the point of view of clinical trial, this arrangement 
certainly caused bias; however these subjects were cancer 
patients, we had to balance ethics and research.
For some patients, the barriers would come from time 
constraints, travel problems, worry about overdoing the 
blood tests, too many visits scheduled, instead of an active 
medicine.
For clinicians, the main barriers come from too few 
patients being referred to the trial, too complicated out-
come measurements, too little time to devote to recruitment 
activities, and too few patients having the disease or problem 
being tested. Insufﬁ  cient recruitment was also due to Western 
doctors’ unsatisfactory attitude to TCM study.
In Hong Kong, because of historical reasons, Western 
medicine is the ofﬁ  cial and mainstream healthcare provision. 
Western doctors trained in modern medicine have fewer oppor-
tunities to be trained in TCM. As they do not understand TCM 
well, they usually don’t want their patients to take TCM before 
and during conventional treatment. This forms a barrier between 
modern medicine and TCM in Hong Kong. As a result, fewer 
candidates were referred to TCM clinical trials by Western 
doctors. For example, when we conducted cancer clinical trials 
using TCM as adjuvant treatment, we often had difﬁ  culties in 
patient recruitment because Western doctors did not encourage 
their patients to take TCM during conventional treatment.
There may be many clinical trials competing for these 
few patients who are willing to participate. Many physicians 
in Hong Kong usually do not encourage their patients to 
consider clinical trial participation, especially TCM clinical 
trials. These certainly increase the difﬁ  culties in subject 
recruitment for TCM clinical trials. Table 3 summarizes the 
difﬁ  culties in recruitment.
When insufficient recruitment occurred, we often 
consider the following steps which included reevaluating 
the required sample size; adding new sites to the trial; fre-
quency of visits; extending the patient recruitment period, and 
modifying the patient inclusion/exclusion criteria. McDonald 
and colleagues (2006) reported that in about 10% of trials 
the inclusion criteria were changed or protocol amended to 
improve recruitment.
Attempts to enhance the recruitment the following 
strategies were tried: a) face-to-face contact with patients 
(eg, presentations at cancer support group); b) print contact 
at selected work sites (eg, ﬂ  yers and posters distributed at 
community); c) notices in mass media (newspapers, journals, 
and broadcast media). In addition, the research team encour-
aged the participants to notify their friends and family 
members who might be eligible for enrollment. Posters and 
ﬂ  yers were delivered to related medical clinics and nonproﬁ  t 
making and nongovernment organizations.
It was important to involve a registered TCM practitioner 
in a TCM clinical trial in order to keep the subjects clear 
from other herbal medicine/functional foods, with vague 
precise deﬁ  nition, and keep the subjects without withdrawal. 
The role of the TCM practitioner was to explain which 
herbal preparations or functional foods are to be avoided 
and provide consultation to the subjects while they were 
taking study medication. But no individualized prescription 
were given. This arrangement strengthened the relationship 
between subjects and investigators and the retention was 
much improved.Patient Preference and Adherence 2008:2 211
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Table 3 Reasons for recruitment barriers
Reasons for recruitment failure Occurred in our traditional Chinese medicine (TCM) 
trials
1 Unwilling to take herbal medication In a clinical trial of “Herbal Formulae KGL ( ) 
for Prevention and Treatment of Several Acute Respiratory 
Syndrome”, some health volunteers were unwilling to take 
study herbal preparation because of the taste.
2 Lack of interest in participating In Danggui Buxue Tang ( ) on symptomatic postmeno-
pausal trial and KGL ( ) for prevention and treatment of 
several acute respiratory syndrome trial, many candidates we 
approached had no interest in clinical trials.
3 History of renal or liver diseases, or active gastrointestinal 
diseases
Some candidates who were eager to participate in TCM trial 
were ineligible because of their renal and liver functions were 
unsatisfactory to the inclusion criteria, eg, diabetic foot ulcer 
trial, lung cancer trial and colorectal cancer trial.
4 Out of the age range In asthma clinical trial, we had to exclude some candidates 
because they were out of the age range.
5 Participating in conﬂ  icting study Some candidates could not be recruited in Danggui Buxue 
Tang ( ) trial as they were participating in other trial of 
hormone replacement therapy.
6 Unwilling to commit to required time Some health volunteers or candidates whose problems were 
not severe, were unwilling to follow the scheduled time, eg, 
Danggui Buxue Tang ( ) and KGL ( ) trial.
7 Not willing to be randomized to nontreatment 
or placebo group
In the trial of Yunzhi and Danshen on immunological function 
in breast cancer patients, nearly all subjects were unwilling 
to take placebo.
8 Unacceptable to some ingredient(s) 
of the TCM formula
Due to intolerance of Danggui, some subjects refused to take 
part in Danggui Buxue Tang ( ) trial.
9 Refusal to traumatizing assessment, 
eg, frequent blood taking
Some health volunteers refused to participate in KGL ( ) 
trial as frequent blood taking was required.
10 Patient with signiﬁ  cant medical problem, 
eg, allergy
Some candidates were excluded as they had history of 
hypersensitivity to drugs (including herbal drugs), eg, asthma 
and allergic rhinitis clinical trials.
11 Unable to comply with the protocol 
requirements, eg, arranged visits, 
appointed visit site, etc.
Some candidates were unable to comply with the scheduled 
visits because of working or trips, eg, in colorectal cancer trial 
some subjects had to work and some wanted to travel.
Recruitment to trials might be increased if information 
given to potential participants was sufﬁ  cient including the 
potential personal beneﬁ  ts and risks.
Frequent contact with subjects is essential for maintain-
ing volunteer motivation to keep them stay in the study. We 
had a TCM practitioner involved in the trial to interpret the 
individual herb properties of the study herbal formulation and 
answer the questions raised by subjects during study period. 
This arrangement worked well in subject retention.
Discussion: Possible solutions
Traditional Chinese Medicine has a long history but its efﬁ  cacy 
is not well-documented according to the requirements of 
evidence-based medicine (EBM). Proof of efﬁ  cacy has to come 
from clinical trials (Ernst 2006). The design and reporting of 
clinical trials of TCM should follow the same guidelines as those 
for Western medicine (Ioannidis et al 2004). The diagnosis and 
treatment of TCM is based on overall analysis of the symptoms 
and signs. The treatments are frequently not standardized, but 
individualized and ﬂ  exible, adjusting treatment as needed for 
the individual patient. In addition, there are wide variations 
and unrepeatable in practice. These are the common attitude of 
public. When we conduct a TCM clinical trial in compliance 
with randomized control trial principles, it is no doubt that we 
have a lot of barriers and difﬁ  culties in patient recruitment 
and retention apart from the clinical trial design. Based on our 
previous experience in TCM clinical trials we believe that the 
following issues may be helpful in patient recruitment.
Proper evaluating inclusion criteria
Inclusion criteria which are too strict may bar many subjects 
from entering the study. We used to exclude all subjects Patient Preference and Adherence 2008:2 212
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who were taking herbal preparation as dietary supplements. 
These strict inclusion criteria made the recruitment dif-
ﬁ  cult because about 50% to 60% of the population in Hong 
Kong have consulted TCM practitioners (Wong et al 1995). 
According to a survey conducted by Critchley and colleagues 
(2005), in 259 surveyed adult Chinese patients admitted to 
a Hong Kong teaching hospital, 90% used Chinese herbs on 
a regular daily basis in traditional soups and teas while 44% 
had consulted a TCM practitioner in the last twelve months 
prior to admission, but mainly for health promotion (59%) 
and minor ailments (30%). Only 25% sought advice for 
their current illness and 13% were taking regular traditional 
Chinese medicines prior to admission. The ingredients were 
difﬁ  cult to identify. The use of Chinese herbs in Chinese com-
munities is very popular. If we exclude the subjects who take 
herbal preparations as dietary supplement or as medication, 
we would have great difﬁ  culties. To balance the recruitment 
accrual and result objectivity, we should encourage the eli-
gible subject to stop taking other herbal preparations before 
and during study period. However, if the subject is not willing 
to quit, we had to advise the patient to just use the same herbal 
preparation at the same dosage throughout the study period. 
It would be useful for later data analysis if we had accurate 
information about the exact herbs being consumed.
Apart from the inclusion criteria, it was possible that 
recruitment effects were hampered by patients’ perceived 
factors although these factors were not speciﬁ  c for TCM 
clinical trials as follows:
1.  An exceedingly long clinical trial
2.  Too many clinic visits
3.  Too many tests conducted at each visit
4.  Clinic visits that are inconvenient in terms of the number 
of hours required
5.  Clinic visits that are inconvenient in terms of the time 
of day
6.  Too great a chance of receiving a placebo instead of an 
active medicine.
Improving the quality of interactions 
with patients
All staff that interacted with patients during the recruitment 
process should be evaluated for the appropriateness and 
professionalism of their practice. This includes enthusiasm 
for the project, willingness to accept extra duties, empathy 
for the patient, and ability to discuss clearly the values and 
limitations of the trial. Experienced patients could be asked 
to share their experiences. We believe that the collaboration 
between research nurse and TCM practitioner in the process 
of patient recruitment and retention would signiﬁ  cantly 
improve the efﬁ  ciency and effect.
Shifting placebo-controlled to active-
controlled arrangements if possible
A meta-analysis of dropout rate comparison in the active 
treatment and placebo treatment revealed that use of a 
placebo-controlled design had a major effect on the drop-
out rates (Kemmler et al 2005; McDonald et al 2006). The 
dropout rates may be higher in the placebo group than in the 
active group because of the lack of efﬁ  cacy of placebo, which 
caused patients to leave the study prematurely. In recent 
years, ethical objections have been raised against the use of 
a placebo “treatment” once an efﬁ  cacious standard treatment 
has been established. To replace the placebo-controlled arm 
with an active-controlled arm will be very helpful in patient 
retention if this change does not inﬂ  uence the outcome of 
the clinical trial.
Interest and motivation
Our patient population would have little incentive to 
participate in a placebo-controlled trial on TCM because they 
did not want to take the risk of being randomized to a placebo 
group. Subjects who believe the study herbal product may 
help them are likely to simply purchase the product from the 
market if it was commercially available. For incentive pur-
poses we usually promise to provide the real medication free 
of change to participants who were randomized to receive 
the placebo at the end of the trial although this arrangement 
would not satisfy all.
In general, recruitment was difﬁ  cult in clinical trials, 
and the refusal rate was high. A study reported (Mok et al 
2007) that 322 patients were screened and offered consent, 
but only 120 agreed to participate. Seventy-nine patients 
(39.2%) could not accept the placebo-controlled design, 
45 patients (22.3%) had already been taking Chinese herbal 
preparation before starting chemotherapy, and the rest either 
refused without a reason or were not interested. According a 
report (Wong et al 1995), 350 patients suitable for inclusion 
in the trial, 123 (35%) refusal to take part and 51 (15%) were 
excluded because they were unable to provide consent or 
relative assent.
Successful recruitment of participants is the key step to 
success in achieving the study aims. This paper described 
our reasoning, experiences, and the strategies we adopted 
to maximize recruitment during TCM clinical studies. 
Our experiences tell us that recruiting through the health 
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nongovernmental organisations, is likely to be less successful 
than open advertising, as doctors in hospitals or clinics often 
have other priorities. Patient support groups may also be 
helpful. It is important that someone is assigned to telephone 
duty to deal with initial contact to avoid loss of potential 
volunteers. TCM clinical trials require a wide range of skills 
to successfully recruit subjects, in particular organization and 
oral communication skills. It is important to think ahead and 
to pre-empt volunteer queries. Frequent contact, including 
brieﬁ  ng and debrieﬁ  ng meetings is essential for maintaining 
volunteer motivation to stay in the study. The newspaper 
articles could attract attentions of potential participants 
within a short period and was faster in efﬁ  ciency and less 
expensive. However since the article or interview was only 
placed a few days in a week, it is not possible to estimate 
how many people were exposed to this, so overall response 
rates cannot be determined.
Conclusions
Success in reaching target recruitment depended largely 
on being able to directly contact patients through media 
such as newspaper advertisements, television interviews, 
and physician referrals in hospitals. Suspicions against 
the possibility of being included in the placebo group, and 
unwillingness to stop taking other herbal supplements made 
recruitment more difﬁ  cult, more time-consuming, and costly. 
In a Chinese community, open advertising in a local news-
paper might be a particularly attractive option.
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